Table III.
Identification of risk factors prognostic of overall survival in NMSC cases (n = 123)*
| Risk factors | n/N (%)† | 5-y Overall survival ± SE (%) | P value‡ |
|---|---|---|---|
| Prolonged immunosuppression | |||
| Yes | 16 (13) | 84 ± 10.8 | .2 |
| No | 107 (87) | 96 ± 2.5 | |
| Radiation therapy | |||
| Yes | 20 (16) | 95 ± 4.9 | .97 |
| No | 103 (84) | 93 ± 3.5 | |
| Chemotherapy | |||
| Yes | 20 (16) | 100 ± 0 | .3 |
| No | 103 (84) | 92 ± 3.5 | |
| Voriconazole use | |||
| Yes | 7 (6) | 53.3 ± 24.8§ | .001 |
| No | 116 (94) | 96.2 ± 2.2§ | |
| Prior oncologic diagnosis | |||
| Yes | 29/121 (24) | 96 ± 3.8 | .7 |
| No | 92/121 (76) | 92 ± 3.8 | |
| HSCT | |||
| Yes | 13 (11) | 77.9 ± 14.1 | .053 |
| No | 110 (89) | 96 ± 2.4 | |
| Organ transplant | |||
| Yes | 7 (6) | 100 ± 0 | .5 |
| No | 116 (94) | 93 ± 3.1 | |
Bold values are P < 0.05 that are statistically significant.
*
One patient is missing survival data.
†
Denominator is 123 unless otherwise specified.
‡
P value of log-rank test.
§
Overall survival estimates are for 3 years.